Three-Level Hepatotoxicity Prediction System Based on Adverse Hepatic Effects.
Liu L, Fu L, Zhang JW, Wei H, Ye WL, Deng ZK, Zhang L, Cheng Y, Ouyang D, Cao Q, Cao DS.
Liu L, et al. Among authors: fu l.
Mol Pharm. 2019 Jan 7;16(1):393-408. doi: 10.1021/acs.molpharmaceut.8b01048. Epub 2018 Dec 14.
Mol Pharm. 2019.
PMID: 30475633